Alpha DNA Investment Management’s Agora API Stock Holding History

Alpha DNA Investment Management’s Portfolio API Stock Details API Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-59	Closed	-$2K	–	134
2021 Q1	$2K	Buy	+59	New	+$3.72K	﹤0.01%	546

Other funds holding API

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

SCIMFI

SIG China Investments Master Fund III Wilimington, Delaware $49K AUM 87.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NAH

Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Alpha DNA Investment Management's API Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Agora (API) in Q2 2021, closing a stake of 59 shares — an estimated $2K sold.

Alpha DNA Investment Management first reported a position in API in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 127 funds tracked by Wall St. Rank hold API as of Q2 2021.

Alpha DNA Investment Management reported no remaining Agora position as of Q2 2021 after selling out during the quarter.
Alpha DNA Investment Management sold 59 Agora shares in Q2 2021, an estimated $2K.
Alpha DNA Investment Management first reported a position in Agora in Q1 2021 and held it in 1 quarter.
Alpha DNA Investment Management's Agora position peaked at $2K in Q1 2021.
127 funds tracked by Wall St. Rank held Agora as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.